Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(8%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
25%
Ph not_applicable
3
25%
Ph phase_2
2
17%
Ph phase_4
4
33%

Phase Distribution

3

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
3(25.0%)
Phase 2Efficacy & side effects
2(16.7%)
Phase 4Post-market surveillance
4(33.3%)
N/ANon-phased studies
3(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(5)
Other(5)

Detailed Status

unknown5
Completed5
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (25.0%)
Phase 22 (16.7%)
Phase 44 (33.3%)
N/A3 (25.0%)

Trials by Status

unknown542%
not_yet_recruiting18%
completed542%
recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12